Celldex Therapeutics (CLDX) Given Daily Coverage Optimism Score of 0.08

HC Wainwright reissued a "buy" rating and issued a $10.00 target price on shares of Celldex Therapeutics in a research note on Tuesday, August 1st. Finally, BidaskClub downgraded shares of Celldex Therapeutics from a "sell" rating to a "strong sell" rating in a research note on Monday, July 24th. Zacks Investment Research downgraded shares of Celldex Therapeutics from a "buy" rating to a "hold" rating in a research note on Tuesday, June 27th. Finally, Cowen and Company restated a buy rating on shares of Celldex Therapeutics in a research report on Tuesday, June 6th. The scale runs from 1 to 5 with 1 recommending Strong Buy and 5 recommending a Strong Sell. The stock has a consensus rating of "Hold" and a consensus price target of $7.32.

To shift focus on performance of the Celldex Therapeutics, Inc.

Celldex Therapeutics, Inc. (CLDX) has the market capitalization of $354.19 Million. Overall, 2.72 Million shares exchanged hands versus its average trading volume of 1.45 Million shares. For CLDX, the company now has $66.16 Million of cash on the books. The company has a 50-day moving average of $2.41 and a 200 day moving average of $2.88. The 5 months chart pattern indicates high risk for the $322.14 million company. Also published the news titled: "Celldex Therapeutics' (CLDX) CEO Anthony Marucci on Q2 2017 Results - Earnings ..." on August 09, 2017. The biopharmaceutical company reported ($0.23) EPS for the quarter, beating the consensus estimate of ($0.28) by $0.05. Next quarter's EPS is forecasted to be $-0.28 with next year's EPS projected to be $-1.00. Return on Equity (ROE) stands at -51.9% and Return on Investment (ROI) of -50.1 percent. The business's revenue was up 175.5% on a year-over-year basis. During the same period in the previous year, the firm earned ($0.32) earnings per share. Celldex Therapeutics, Inc. (NASDAQ:CLDX) has noticeable measure of stock volatility, for this average true range is an exponential moving average (14 trading days) of the True Ranges.

A number of institutional investors have recently added to or reduced their stakes in CLDX. Morgan Stanley's holdings in Celldex Therapeutics were worth $1,835,000 as of its most recent SEC filing. Meditor Group Ltd now owns 5,800,000 shares of the biopharmaceutical company's stock worth $14,326,000 after purchasing an additional 1,654,100 shares during the period. Bank of New York Mellon Corp increased its holdings in Celldex Therapeutics by 1.1% during the 1st quarter. Canada Pension Plan Investment Board boosted its position in shares of Celldex Therapeutics by 106.7% during the 1st quarter. (NASDAQ CLDX) traded up 0.201% during mid-day trading on Wednesday, hitting $2.495. Teachers Advisors LLC boosted its position in shares of Celldex Therapeutics by 0.9% during the 4th quarter. Renaissance Technologies LLC now owns 1,707,927 shares of the biopharmaceutical company's stock worth $6,166,000 after purchasing an additional 508,217 shares during the period. Vanguard Group Inc. now owns 9,774,858 shares of the biopharmaceutical company's stock valued at $24,143,000 after buying an additional 708,095 shares during the last quarter.

Biglari Holdings a holding company owning subsidiaries engaged in various business activities, including media, property and casualty insurance, and restaurants The Company's divisions include Restaurant Operations, First Guard, Maxim, Other and Corporate.

Celldex Therapeutics, Inc. (CLDX)'s RSI (Relative Strength Index) is 59.10. The Company is using the technologies to develop targeted immunotherapeutics consisting of protein-based molecules, such as vaccines, antibodies and antibody-drug conjugates that are used to treat specific types of cancer or other diseases. The Company's lead drug Rintega is a therapeutic vaccine, which is meant for the treatment of glioblastoma patients.

To view ValuEngine's full report, visit ValuEngine's official website.

Like this



13 September 2017
Session Recap: Viewing Unusual Volume for Koninklijke Philips NV (NYSE:PHG)
Koninklijke Philips N.V. (NYSE:PHG)'s market cap, the total dollar value of all of their outstanding shares, is 37488.07m. Northwestern Mutual Wealth Management Co. grew its position in Koninklijke Philips 7.5% during the second quarter.

13 September 2017
Would You Buy Applied Materials, Inc. (NASDAQ:AMAT) On These Analyst Ratings?
Finally, Honkamp Krueger Financial Services Inc. grew its position in shares of Applied Materials by 0.5% in the second quarter. In current trading day Lincoln National Corporation (LNC ) stock confirmed the flow of 2.10% with the final price of $67.18.

13 September 2017
BMW M8 GTE brings BMW back to 24 Hours of Le Mans
There's a massive wing, side skirts, an aggressive front splitter, and huge air intakes, all wrapped in BMW's racing livery. BMW says the head and block are from the production engine, so we can expect the to see the same mill in the street auto .

13 September 2017
Array BioPharma (ARRY) Earning Somewhat Favorable Press Coverage, Analysis Shows
Janney Montgomery Scott Ltd Liability Corporation stated it has 0% of its portfolio in Array Biopharma Inc (NASDAQ:ARRY). Of those analysts, 8 rate stock as a Strong Buy, 1 rate it as Hold, and just no analyst rates it as a Moderate Sell.

13 September 2017
Allergan partners with Indian tribe to protect drug patents
For the tribe, it's a new revenue stream that could lead to more down the road. "We want to be self-reliant". The company is facing challenges to the Restasis patents in front of that board and in federal court.

13 September 2017
Brooklyn food festival ignites outrage by charging $75 for tiny pizza
Osekre was also behind a food festival previous year that was widely panned as a scam, according to Gothamist . But co-owner Jeremy Asgari tells Grub that " Hangry Garden did not end up being involved in this event".

13 September 2017
Ten people died as Hurricane Irma battered Cuba
Majority died in Havana, where chest-deep seawater pushed several blocks into densely populated neighborhoods. National Hurricane Center reported.

13 September 2017
Franklin Resources, Inc. (BEN) Stake Lessened by Westpac Banking Corp
The rating was maintained by Citigroup on Friday, July 29 with "Neutral". (NASDAQ:CYTK) rating on Wednesday, July 27. Nantahala Capital Management Llc holds 1.26% of its portfolio in Owens Realty Mortgage Inc for 654,968 shares.

13 September 2017
Drinking Water Supplies Around Ireland At Risk Of Crytosporidium Infection
The EPA says remedial action is needed at 87 separate "at risk" sources to safeguard water quality for 700,000 people. And 12,823 people are drinking inadequately-treated water in parts of Sligo served by the Lough Talt supply.

13 September 2017
Exelon Corporation (EXC) PT Raised to $40.00 at Morgan Stanley
Finally, State of Tennessee Treasury Department boosted its holdings in shares of Exelon Corporation by 385.6% in the 1st quarter. Investors might also notice that two months ago the Buy recommendations (0) were less than Sell recommendations (0).